계산생물학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Computational Biology Market size is expected to reach USD 24.70 Billion in 2034 from USD 7.80 Billion (2025) growing at a CAGR of 13.67% during 2026-2034.

The global computational biology market is experiencing rapid growth as advanced computing technologies are increasingly integrated into biological and medical research. Computational biology uses algorithms, data modeling, and bioinformatics tools to analyze complex biological data, including genomic and proteomic information. The rising demand for personalized medicine and precision healthcare is significantly boosting the adoption of computational biology solutions in pharmaceutical research and biotechnology development.

Technological advancements such as artificial intelligence, machine learning, and high-performance computing are transforming biological data analysis. These technologies enable researchers to process large volumes of omics data and simulate biological systems more efficiently. The increasing number of clinical studies and growing pharmaceutical R&D activities are also contributing to the expansion of the computational biology market worldwide.

Looking ahead, the market is expected to witness strong growth as drug discovery becomes more data-driven and personalized treatment approaches gain importance. Expanding investments in life sciences research and the development of cloud-based bioinformatics platforms will further support market expansion. As computational tools continue to evolve, they are expected to play a critical role in accelerating medical research and improving healthcare outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Cellular and Biological Simulation
• Computational Genomics
• Computational Proteomics
• Pharmacogenomics
• Others

By Tools

• Databases
• Software
• Services

By End-User

• Academics
• Industry
• Government
• Others

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Dassault Systmes SE, Genedata AG, Chemical Computing Group ULC, Certara LP, Schrdinger Inc, Simulation Plus Inc, Insilico Medicine Inc, Compugen Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Cellular and Biological Simulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Computational Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Computational Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY TOOLS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Tools
• 5.2. Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Academics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Government Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Tools
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Tools
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Tools
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Tools
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Tools
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL COMPUTATIONAL BIOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Illumina Inc
  • 9.2.2 Thermo Fisher Scientific Inc
  • 9.2.3 Agilent Technologies Inc
  • 9.2.4 Dassault SystAfA¨Mes SE
  • 9.2.5 Genedata AG
  • 9.2.6 Chemical Computing Group ULC
  • 9.2.7 Certara L.P
  • 9.2.8 SchrA¶Dinger Inc
  • 9.2.9 Simulation Plus Inc
  • 9.2.10 Insilico Medicine Inc
  • 9.2.11 Compugen Ltd